NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Karolinska Development AB (publ) (ST: KDEV)
KDEV Technical Analysis
5
As on 22nd Nov 2024 KDEV STOCK Price closed @ 1.04 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.62 & Strong Sell for SHORT-TERM with Stoploss of 1.63 we also expect STOCK to react on Following IMPORTANT LEVELS. |
KDEVSTOCK Price
Open | 1.07 | Change | Price | % |
High | 1.10 | 1 Day | -0.04 | -3.70 |
Low | 1.02 | 1 Week | -0.02 | -1.89 |
Close | 1.04 | 1 Month | -0.16 | -13.33 |
Volume | 359812 | 1 Year | -0.57 | -35.40 |
52 Week High 1.88 | 52 Week Low 1.00 |
ST Sweden Most Active Stocks
TANGI | 0.00 | % |
FING-B | 0.08 | 0.00% |
SBB-B | 4.00 | 1.78% |
LUNE | 21.97 | 6.65% |
SNM | 0.88 | 2.33% |
DIABIO | 0.03 | 0.00% |
WYLD | 0.02 | 0.00% |
NIBE-B | 45.75 | 1.87% |
HDW-B | 0.00 | % |
EURA | 0.01 | 0.00% |
ST Sweden Top Gainers Stocks
ST Sweden Top Losers Stocks
KDEV Daily Charts |
KDEV Intraday Charts |
Whats New @ Bazaartrend |
KDEV Free Analysis |
|
KDEV Important Levels Intraday
RESISTANCE | 1.19 |
RESISTANCE | 1.14 |
RESISTANCE | 1.11 |
RESISTANCE | 1.08 |
SUPPORT | 1.00 |
SUPPORT | 0.97 |
SUPPORT | 0.94 |
SUPPORT | 0.89 |
KDEV Forecast November 2024
4th UP Forecast | 1.58 |
3rd UP Forecast | 1.41 |
2nd UP Forecast | 1.3 |
1st UP Forecast | 1.19 |
1st DOWN Forecast | 0.89 |
2nd DOWN Forecast | 0.78 |
3rd DOWN Forecast | 0.67 |
4th DOWN Forecast | 0.5 |
KDEV Weekly Forecast
4th UP Forecast | 1.31 |
3rd UP Forecast | 1.22 |
2nd UP Forecast | 1.17 |
1st UP Forecast | 1.12 |
1st DOWN Forecast | 0.96 |
2nd DOWN Forecast | 0.91 |
3rd DOWN Forecast | 0.86 |
4th DOWN Forecast | 0.77 |
KDEV Forecast2024
4th UP Forecast | 2.97 |
3rd UP Forecast | 2.35 |
2nd UP Forecast | 1.97 |
1st UP Forecast | 1.59 |
1st DOWN Forecast | 0.5 |
2nd DOWN Forecast | 0.11 |
3rd DOWN Forecast | -0.27 |
4th DOWN Forecast | -0.89 |
Karolinska Development AB (publ) ( ST Sweden Symbol : KDEV )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
KDEV Other Details
Segment | EQ | |
Market Capital | 805182400.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
KDEV Address
KDEV Latest News
KDEV Business Profile
Karolinska Development AB (publ) is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark. It prefers to be a lead investor in its portfolio companies however does consider co-investments also. It seeks to invest in up to five projects annually. Karolinska Development AB (publ) was founded in 2003 and is headquartered in Stockholm, Sweden. Address: Tomtebodavägen 23 A, Solna, Sweden, 17165
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service